Ondansetron
Brand name: Ondansetron Odt
Rank #407 of 500 drugs by total cost
$21.5M
Total Cost
1,261,950
Total Claims
$21.5M
Total Cost
50,152
Prescribers
$17
Cost per Claim
699,756
Beneficiaries
1,288,700
30-Day Fills
$429
Avg Cost/Provider
25
Avg Claims/Provider
About Ondansetron
Ondansetron (sold as Ondansetron Odt) was prescribed 1,261,950 times by 50,152 Medicare Part D providers in 2023, costing the program $21.5M. At $17 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology